FORT WORTH, Texas–(BUSINESS WIRE)–Galderma, the leading company solely dedicated to advancing the future of dermatology, announced it will present four scientific presentations at the 2022 Vegas Cosmetic Surgery (VCS) & Aesthetic Dermatology Annual Symposium to showcase the latest advancements surrounding its approved and investigational product updates. “We look forward to unveiling the latest data and … [Read more…]

StatLab expands global reach and core manufacturing capabilities with CellPath Ltd. acquisition MCKINNEY, Texas–(BUSINESS WIRE)–StatLab Medical Products (StatLab), an Audax Private Equity and Linden Capital Partners portfolio company and a leading developer and manufacturer of medical diagnostic supplies and equipment, today announced that it has acquired CellPath Ltd. (CellPath), a UK-based manufacturer and supplier of … [Read more…]

BASINGSTOKE, England–(BUSINESS WIRE)–It is with great pleasure that Juniper Research announces the 2022 winners of the Future Digital Awards for Digital Health Innovation. This year’s awards received a record number of applications; making choosing winners more difficult than ever. These awards recognise the most innovative and impactful digital health solutions operating across numerous areas, including … [Read more…]

BOSTON & TORONTO–(BUSINESS WIRE)–Exchange Solutions, a personalized loyalty solutions provider, and Rexall Pharmacy Group have enhanced their loyalty management partnership by launching new loyalty program functionality for Be Well™ members. Automated, personalized offers for members will be distributed through the existing offer gallery available in the Be Well app and online profile, powered by Exchange … [Read more…]

Wellcome Centre for Cell-Matrix Research is funding a nanobody screening project leveraging Carterra’s platform MANCHESTER, England & SALT LAKE CITY–(BUSINESS WIRE)–The University of Manchester, United Kingdom, and Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, announced today that the University of Manchester has added Carterra’s LSA instrument to its Biomolecular Analysis Core … [Read more…]

SHANGHAI & SUZHOU, China–(BUSINESS WIRE)–EpimAb Biotherapeutics, a clinical-stage biotechnology company specializing in bispecific antibody development, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for a Phase Ib/II study in patients with non-small cell lung cancer (NSCLC) evaluating the combination of EMB-01, a bispecific antibody designed … [Read more…]

WASHINGTON–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) welcomes the U.S. Federal Trade Commission (FTC) announcement today that it will launch an inquiry into the practices of prescription drug middlemen and their questionable conduct. “Thank you, FTC, for hearing the voices of tens of thousands of pharmacies and patients across the country and launching an inquiry into the … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) (the “Company” or “Consensus”) announced today the commencement of an underwritten offering of 2,000,000 shares of its common stock currently owned by Ziff Davis, Inc. (“Ziff Davis”), Consensus’s former parent company. Consensus is not selling any shares and will not receive any proceeds from the sale of … [Read more…]

Board and Management Acquired Approximately 135,000 Shares of VIQ Solutions Through Open Market Purchases PHOENIX, Ariz.–(BUSINESS WIRE)–VIQ Solutions Inc. (“VIQ” or the “Company”) (TSX: VQS and Nasdaq: VQS), a global provider of secure, AI-driven, digital voice and video capture technology and transcription services, announced the voting results from its annual and special meeting of shareholders … [Read more…]

LA JOLLA, Calif.–(BUSINESS WIRE)–DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced the grant to one new employee of stock options to purchase an aggregate of 135,397 shares of the Company’s common stock at an exercise price of $6.35 per share and … [Read more…]